"Peter Lynch noted that insiders sell for various reasons but buy only when they believe the stock price will rise. Mark Bertolini's recent purchase suggests confidence in Oscar Health despite its declining stock price."
"Bertolini's acquisition of 1,000,000 shares through a private placement raised his ownership to 10.87%. This method allowed Oscar to receive $11.92 million in cash without diluting existing shares."
"Private placements provide speed and avoid market impact, allowing companies to raise capital efficiently. However, Oscar's significant operating losses complicate the interpretation of Bertolini's purchase."
Mark Bertolini, CEO of Oscar Health, purchased 1,000,000 shares at $11.92 each, increasing his ownership to 10.87%. This purchase was a private placement, not an open-market buy. The transaction provided Oscar with $11.92 million in cash while Bertolini's stake grew. Private placements avoid public exchange complexities, allowing for quick capital infusion without market impact. Despite the purchase, Oscar reported significant operating losses, raising questions about the implications of this insider buy.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]